SC dismisses plea seeking protection of IT employees against layoffs, pay cuts

The petition was filed in the wake of termination of employees and pay cuts despite the advisories issued by the Centre and state governments.

Swathi Moorthy

May 15, 2020 / 19:41 IST

26 Aug, 2025 12:21

Volume

Todays L/H

The Supreme Court on May 15 dismissed a public interest litigation seeking protection of IT employees against termination and salary cuts in the wake of the COVID-19 pandemic.

The bench, headed by Justice L Nageswara Rao, Sanjay Kishan Kaul and BR Gavai, turned down the plea. The PIL was filed by the National Information Technology Employees Senate (NITES), a Maharashtra-based IT union.

The order, dismissing the petition, read, “We are not inclined to entertain this petition under Article 32 of the Constitution of India. The writ petition is accordingly dismissed.”

Article 32 provides the right to Constitutional remedies which means that a person has the right to move the Supreme Court (and high courts also) for getting his fundamental rights protected.

The petition aimed to ensure that employees working in private companies are protected and not illegally sacked against their rights guaranteed under Articles 14, 19(1)(g) and 21.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show